Can a cancer drug treat a rare cardiac disease?
A study by a Yale scientis suggests that dasatinib and similar drugs at low doses could be effective treatment for cardiovascular defects related to Noonan syndrome (NS), a genetic disorder that results in severe heart defects, and should be considered for clinical trials.
Watch Out for These COVID Heart Symptoms, Says Doctor
According to the American Heart Association, nearly one-fourth of those hospitalized with have been diagnosed with cardiovascular complications, which have been shown to contribute to roughly 40% of all COVID-19-related deaths.Source: Eat This, Not That!
Registries could offer insight into COVID-19's impact on college athletes' hearts
Researchers are soon expected to release initial findings from a national cardiac registry of NCAA athletes who have tested positive for COVID-19, giving hope to health care professionals trying to better understand the impact of the disease on the heart.Source: American Heart Association News
Early, Large LDL Reduction Tied to Lowest Event Rates After MI
In registry data covering more than 40,000 patients with myocardial infarction followed for almost 4 years, those with the largest early reductions in LDL-C appeared to reap the greatest reductions in adverse cardiovascular events.Source: Medscape